[TRANSAMINASES, LACTATE DEHYDROGENASE AND SORBITOL DEHYDROGENASES IN SERUM IN MYOTONIC DYSTROPHY TREATED WITH METHANDROSTENOLONE (17ALPHA-17BETA-HYDROXY-ANDROSTA-1,4-DIEN-3-ON)].
D000410:Alanine Transaminase; D045930:Anabolic Agents; D001219:Aspartate Aminotransferases; D001769:Blood; D004796:Clinical Enzyme Tests; D051263:D-Alanine Transaminase; D007064:L-Iditol 2-Dehydrogenase; D007770:L-Lactate Dehydrogenase; D008696:Methandrostenolone; D009223:Myotonic Dystrophy; D010088:Oxidoreductases; D013256:Steroids; D000637:Transaminases
D045930:Anabolic Agents; D013256:Steroids; D008696:Methandrostenolone; D010088:Oxidoreductases; D007064:L-Iditol 2-Dehydrogenase; D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D051263:D-Alanine Transaminase
ALANINE AMINOTRANSFERASE; ANABOLIC STEROIDS; ASPARTATE AMINOTRANSFERASE; BLOOD; ENZYME TESTS; LACTATE DEHYDROGENASE; METHANDROSTENOLONE; MYOTONIA ATROPHICA; OXIDOREDUCTASES
TRANSAMINASEN, LACTATDEHYDROGENASE UND SORBITDEHYDROGENASE IM SERUM BEI MYOTONISCHER DYSTROPHIE UNTER METHANDROSTENOLON (17ALPHA-METHYL-17BETA-HYDROXYANDROSTA-1,4-DIEN-3-ON)-BEHANDLUNG.